Click here to get full coverage on BINV: Robust clinical and financial momentum, with pivotal trial milestones and partnering on the horizon - TradingView

BINV: Robust clinical and financial momentum, with pivotal trial milestones and partnering on the horizon  TradingView

BINV: Robust clinical and financial momentum, with pivotal trial milestones and partnering on the horizon - TradingView

Click here to get full coverage on Liquidity Mapping Around (BINV) Price Events - Stock Traders Daily

Liquidity Mapping Around (BINV) Price Events  Stock Traders Daily

Liquidity Mapping Around (BINV) Price Events - Stock Traders Daily

Click here to get full coverage on We're Not Very Worried About BioInvent International's (STO:BINV) Cash Burn Rate - simplywall.st

We're Not Very Worried About BioInvent International's (STO:BINV) Cash Burn Rate  simplywall.st

We're Not Very Worried About BioInvent International's (STO:BINV) Cash Burn Rate - simplywall.st

Click here to get full coverage on BINV: Strong clinical progress and improved financials position the company for key 2026 oncology milestones - TradingView

BINV: Strong clinical progress and improved financials position the company for key 2026 oncology milestones  TradingView

BINV: Strong clinical progress and improved financials position the company for key 2026 oncology milestones - TradingView

Click here to get full coverage on BioInvent International AB (publ) (STO:BINV): When Will It Breakeven? - simplywall.st

BioInvent International AB (publ) (STO:BINV): When Will It Breakeven?  simplywall.st

BioInvent International AB (publ) (STO:BINV): When Will It Breakeven? - simplywall.st

Click here to get full coverage on BINV: Brandes, The Iconic Value Stock Investor, In ETF Form (BATS:BINV) - Seeking Alpha

BINV: Brandes, The Iconic Value Stock Investor, In ETF Form (BATS:BINV)  Seeking Alpha

BINV: Brandes, The Iconic Value Stock Investor, In ETF Form (BATS:BINV) - Seeking Alpha

Click here to get full coverage on B Investments Holding: Quiet Consolidation Or Calm Before A Breakout? - AD HOC NEWS

B Investments Holding: Quiet Consolidation Or Calm Before A Breakout?  AD HOC NEWS

B Investments Holding: Quiet Consolidation Or Calm Before A Breakout? - AD HOC NEWS

Click here to get full coverage on Investors Don't See Light At End Of BioInvent International AB (publ)'s (STO:BINV) Tunnel And Push Stock Down 26% - simplywall.st

Investors Don't See Light At End Of BioInvent International AB (publ)'s (STO:BINV) Tunnel And Push Stock Down 26%  simplywall.st

Investors Don't See Light At End Of BioInvent International AB (publ)'s (STO:BINV) Tunnel And Push Stock Down 26% - simplywall.st

Click here to get full coverage on Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy - Nature

Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy  Nature

Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy - Nature

Click here to get full coverage on BiNV bond: A hole-transfer bridge for high-efficient separation and transfer of carriers - ScienceDirect.com

BiNV bond: A hole-transfer bridge for high-efficient separation and transfer of carriers  ScienceDirect.com

BiNV bond: A hole-transfer bridge for high-efficient separation and transfer of carriers - ScienceDirect.com

Click here to get full coverage on Category 1 Recommendation of Ribociclib Plus an AI Represents Huge Advancement in Breast Cancer - OncLive

Category 1 Recommendation of Ribociclib Plus an AI Represents Huge Advancement in Breast Cancer  OncLive

Category 1 Recommendation of Ribociclib Plus an AI Represents Huge Advancement in Breast Cancer - OncLive

Click here to get full coverage on BioInvent Taps Industry Heavyweights for Board as Cancer Pipeline Advances - TipRanks

BioInvent Taps Industry Heavyweights for Board as Cancer Pipeline Advances  TipRanks

BioInvent Taps Industry Heavyweights for Board as Cancer Pipeline Advances - TipRanks

Click here to get full coverage on Oncurious, BioInvent start trial to revitalize Roche-rejected cancer drug - Fierce Biotech

Oncurious, BioInvent start trial to revitalize Roche-rejected cancer drug  Fierce Biotech

Oncurious, BioInvent start trial to revitalize Roche-rejected cancer drug - Fierce Biotech

Click here to get full coverage on Vodafone Egypt Raises its Stakes in Bee and Masary - TechAfrica News

Vodafone Egypt Raises its Stakes in Bee and Masary  TechAfrica News

Vodafone Egypt Raises its Stakes in Bee and Masary - TechAfrica News

Click here to get full coverage on BioInvent Announces Nomination of Two New Board Members Ahead of 2026 Annual General Meeting - TradingView

BioInvent Announces Nomination of Two New Board Members Ahead of 2026 Annual General Meeting  TradingView

BioInvent Announces Nomination of Two New Board Members Ahead of 2026 Annual General Meeting - TradingView

Click here to get full coverage on University enters into research collaboration with BioInvent - University of Southampton

University enters into research collaboration with BioInvent  University of Southampton

BINV

Price Chart

Key Statistics

Technicals

About BINV

Latest News

BINV: Robust clinical and financial momentum, with pivotal trial milestones and partnering on the horizon - TradingView

Liquidity Mapping Around (BINV) Price Events - Stock Traders Daily

We're Not Very Worried About BioInvent International's (STO:BINV) Cash Burn Rate - simplywall.st

Advanced Charts

Top Gainers

Top Losers